Published in

SSRN Electronic Journal, 2019

DOI: 10.2139/ssrn.3416687

Elsevier, EBioMedicine, (49), p. 106-117, 2019

DOI: 10.1016/j.ebiom.2019.10.012

Links

Tools

Export citation

Search in Google Scholar

An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO